新闻
STE
--
0.00%
--
STERIS (STE) Q4 Earnings Surpass Estimates, Gross Margin Rises
Robust performances across all four reporting segments drive STERIS' (STE) fiscal fourth-quarter revenues.
Zacks · 3天前
--Needham Lowers Price Target for STERIS to $248 From $263, Maintains Buy Rating
MT Newswires · 3天前
BRIEF-Steris Announces Results For Fiscal 2022 Fourth Quarter And Full Year
reuters.com · 4天前
Steris: Q4 Earnings Insights
Steris (NYSE:STE) reported its Q4 earnings results on Wednesday, May 11, 2022 at 04:30 PM. Here's what investors need to know about the announcement. Earnings Steris beat estimated earnings by 0.99%, reporting an EPS of $2.04 versus an estimate of $2.02.
Benzinga · 4天前
Steris Non-GAAP EPS of $2.04 beats by $0.02, revenue of $1.2B beats by $30M
Steris press release (NYSE:STE): Q4 Non-GAAP EPS of $2.04 beats by $0.02. Revenue of $1.2B (+37.4% Y/Y) beats by $30M. Outlook: For fiscal 2023, constant currency organic revenue growth is
Seekingalpha · 4天前
Steris Q4 EPS $2.04 Beats $2.02 Estimate, Sales $1.20B Beat $1.19B Estimate
Steris (NYSE:STE) reported quarterly earnings of $2.04 per share which beat the analyst consensus estimate of $2.02 by 0.99 percent. This is a 25.15 percent increase over earnings of $1.63 per share from the same period
Benzinga · 4天前
STERIS Announces Financial Results for Fiscal 2022 Fourth Quarter and Full Year
Fourth quarter revenue increases 39% as reported; 11% constant currency organicAs reported EPS of $0.52; adjusted EPS of $2.04Company provides FY23 outlook DUBLIN, IRELAND, May 11, 2022 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”)...
GlobeNewswire · 4天前
STERIS Fiscal Q4 Adjusted EPS, Revenue Rise; Sets Fiscal 2023 Guidance
MT Newswires · 4天前
Steris FQ4 2022 consensus EPS, revenue estimates up
Steris (NYSE:STE) FQ4 consensus EPS estimate is $2.02 (+23.9% Y/Y) and consensus revenue estimate is $1.17B (+33.9% Y/Y). STE is scheduled to announce FQ4 earnings results on Wednesday, May 11, after market close.
Seekingalpha · 5天前
STERIS (STE) to Report Q4 Earnings: What's in the Cards?
Strength in Healthcare and AST arms is expected to have driven STERIS' (STE) fourth-quarter revenues.
Zacks · 05/06 14:56
Investing in STERIS (NYSE:STE) five years ago would have delivered you a 220% gain
The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...
Simply Wall St. · 05/05 12:19
Steris declares $0.43 dividend
Steris (NYSE:STE) declares $0.43/share quarterly interim dividend, in line with previous. Forward yield 0.74% Payable June 28; for shareholders of record June 14; ex-div June 13. See STE Dividend Scorecard,
Seekingalpha · 05/04 20:36
STERIS Declares $0.43 per share Dividend
DUBLIN, IRELAND , May 04, 2022 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.43 per share. The dividend is payable June 28, 2022 to shareholders of...
GlobeNewswire · 05/04 20:30
Here's Why You Should Retain Quest Diagnostics (DGX) Stock Now
Investors are optimistic about Quest Diagnostics (DGX) owing to a strong recovery in base business and raised 2022 outlook.
Zacks · 05/03 13:30
STERIS to Host a Conference Call for Fiscal 2022 Fourth Quarter and Full Year Financial Results on May 12, 2022
DUBLIN, IRELAND, April 25, 2022 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2022 fourth quarter and full year financial results at 10:00 a.m. ET on May 12,...
GlobeNewswire · 04/25 20:30
Globus Medical (GMED) Stock Fell on Preliminary Q1 Sales Results
Globus Medical's (GMED) Q1 preliminary sales results reflect an increase in procedural volumes along with growth in Enabling Technologies business.
Zacks · 04/22 15:05
Insider Sell: Steris
MT Newswires · 04/21 17:35
Zacks Industry Outlook Highlights Alcon, STERIS and Abiomed
Alcon, STERIS and Abiomed have been highlighted in this Industry Outlook article.
Zacks · 04/20 10:21
Here's Why You Should Retain Bio-Rad (BIO) Stock For Now
Investors are optimistic about Bio-Rad (BIO) owing to a recovery in most of its key global markets as well as an uptick in demand for COVID-related products.
Zacks · 04/19 14:19
Thermo Fisher (TMO) Debuts GMP-Manufactured Cas9 Protein
Thermo Fisher's (TMO) Gibco CTS TrueCut Cas9 Protein to support genome editing for research and manufacturing applications.
Zacks · 04/19 14:14
微牛提供丰富的实时STE股票新闻,让你可以通过多个平台了解STE股票行情最新动态,这些免费的思泰瑞医疗新闻可以帮助你做出明智投资。
STE 简况
Steris plc是一家提供感染预防和其他程序性产品和服务的公司。该公司提供多种消耗品,如洗涤剂、胃肠道(GI)内窥镜配件、屏障产品解决方案以及其他产品和服务,包括:设备安装和维护、医疗器械的微生物减少、牙科仪器和工具、仪器和范围维修解决方案,实验室测试服务、外包后处理和资本设备产品,如消毒器和手术台、自动内窥镜后处理器,以及连接解决方案,如手术室(OR)集成。该公司通过四个可报告的业务部门运营:医疗保健、应用消毒技术、生命科学和牙科。其医疗保健部门专注于无菌处理部门和程序中心,如手术室、内窥镜检查室和肾透析中心。